Agenparl (Itália)

Study helps to deeper understanding of brain dysfunctions in patients with schizophrenia

Publicado em 08 junho 2021

(AGENPARL) – WORCESTER (MASSACHUSETTS), lun 07 giugno 2021 (Fundação de Amparo à Pesquisa do Estado de São Paulo) Researchers used protein mapping to show how abnormal levels of the neurotransmitter glutamate impair the functioning of neurons and oligodendrocytes. The findings could serve as a basis for more effective treatment.